Prostaglandin analogues and phosphodiesterase inhibitors, either alone or as add-on therapy, are effective treatments for vitiligo repigmentation.

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...

In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...

Vitiligo is a skin condition that’s little understood and it often takes a long time to diagnose, but now a new treatment could help to cure it. It currently affects around 70 million people around ...

After your initial diagnosis, it's possible for vitiligo to spread to other areas of the body, but it's not a guarantee. Because there is no cure or treatment, it's impossible to predict or stop that ...

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

When Jordan Emanuel began filming the latest season of Bravo TV’s Summer House: Martha’s Vineyard, she wasn’t sure if she’d ...

The biotech startup will use the funds to assist its Phase II human clinical trials for its drug candidate for vitiligo.

VASI is a valid and reliable tool that is responsive to change and has defined thresholds for meaningful improvement for patients with vitiligo.

A 75-year-old woman with rheumatoid arthritis and multiple myeloma was admitted to the hospital with abdominal pain. She had ...